United States
Germany
Japan
United Kingdom
China
Recombinant Anti-CD52 (Clone Campath-1H)
| Applications | CT, ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
Antibodies
CS1 monoclonal antibody (elotuzumab biosimilar)
| Applications | ELISA, FC |
| Reactivities | Human |
IL6 monoclonal antibody (siltuximab biosimilar)
| Applications | ELISA, FC |
| Reactivities | Human |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
CNY 6,881.00
6周
Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
| Applications | Bl, ELISA, FC, IF, IHC |
| Reactivities | Human |
CNY 6,881.00
6周
Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
| Applications | Bl, ELISA, FC, IF, IHC |
| Reactivities | Human |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | Bl, ELISA, FC, IHC |
| Reactivities | Human, Chimpanzee |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
Anti-5T4 (GEN-1044 biosimilar) mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Anti-GUCY2C(indusatumab biosimilar) mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Anti-5T4 (H8 biosimilar) mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Anti-Nectin-4(enfortumab biosimilar) mAb
| Applications | ELISA, FC |
| Reactivities | Human |
